ProQR Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts that cover ProQR Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $7.25, which forecasts a 358.86% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $9.00.

Price Target: $7.25 (+358.86%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$7.25	$8.00	$9.00
Change	+153.16%	+358.86%	+406.33%	+469.62%

* Price targets were last updated on Apr 9, 2026.

Analyst Ratings

The average analyst rating for ProQR Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	3	3	3	3	3	1
Buy	4	4	4	4	4	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $4	Strong Buy	Maintains	$4	+153.16%	Apr 9, 2026
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $4	Strong Buy	Maintains	$4	+153.16%	Nov 4, 2025
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $4	Strong Buy	Maintains	$4	+153.16%	Aug 8, 2025
Timur Ivannikov Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $8	Buy	Reiterates	$8	+406.33%	Jun 27, 2025
Jonathan Wolleben JMP Securities	JMP Securities	Buy Reiterates $8	Buy	Reiterates	$8	+406.33%	Jun 27, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

20.48M

from 16.35M

25.28%

from 16.35M

Revenue Next Year

18.97M

from 20.48M

-7.38%

from 20.48M

EPS This Year

-0.53

from -0.40

EPS Next Year

-0.64

from -0.53

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.38M	4.36M	6.59M	19.55M	16.35M	20.48M	18.97M
Revenue Growth	131.10%	83.30%	51.27%	196.41%	-16.36%	25.28%	-7.38%
EPS	-0.95	-0.90	-0.35	-0.32	-0.40	-0.53	-0.64
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	8

Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	24.1M	31.0M
Avg	20.5M	19.0M
Low	18.0M	8.8M

Revenue Growth

Revenue Growth	2026	2027
High	47.7%	51.2%
Avg	25.3%	-7.4%
Low	10.3%	-56.9%

EPS Forecast

EPS	2026	2027
High	-0.39	-0.39
Avg	-0.53	-0.64
Low	-0.80	-1.03

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.